10 compounds
Endocrine
Growth-hormone axis and hormonal signalling research
CJC-1295 (DAC)
Studied in growth-hormone research; the DAC form stays in circulation far longer than the plain form.
CJC-1295 + Ipamorelin
Studied together in combination protocols: CJC-1295 and ipamorelin, two routes to growth-hormone release.
CJC-1295 (no DAC)
Studied in models of the natural pulse pattern of growth-hormone release.
Hexarelin
Studied at the growth-hormone secretagogue receptor, including the same receptor in heart tissue.
Ipamorelin
Studied as a selective ghrelin-receptor ligand, with little activity at related receptors.
Kisspeptin-10
Studied in the signalling step upstream of GnRH, the hormone that starts the reproductive cascade.
Oxytocin
Studied in where its receptors sit in the brain and in bonding-behaviour animal models.
PT-141 (Bremelanotide)
Studied at melanocortin receptors in the central nervous system.
Sermorelin
Studied in pituitary-release research and the growth-hormone and IGF-1 pathway.
Tesamorelin
Studied in growth-hormone research, including adipose-tissue distribution models.
Endocrine research
All articlesWhat the published literature on these compounds actually examined — the model, the endpoint, and the result.
Endocrine
The growth-hormone axis, and four ways to poke it
GHRH analogues and ghrelin-receptor peptides push growth hormone in different ways. That difference is the whole story.
Endocrine
Upstream of GnRH: kisspeptin, and the oxytocin comparison
Kisspeptin sits at the top of the reproductive chain and was found through a genetic disorder. Oxytocin is the opposite case: long known, still widening.